Form 4 for STE Steris
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-04 · accession 0001628280-24-027069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-06 | 2024-06-04 | STE | Madsen Julia | Senior VP, Life Sciences | A - Grant | $0.00 | +1,626 | 9,671 | +20% | $0 |
| D | 2024-06-06 | 2024-06-04 | STE | Madsen Julia | Senior VP, Life Sciences | A - Grant | $0.00 | +8,336 | 8,336 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-06-04 | A | A | 1,626 | $0.00 | 9,671 | D | — | — | (F1) As of June 4, 2024, 4,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025; 144 on October 1, 2025; 578 on June 1, 2026; 352 on June 2, 2026; 542 on June 4, 2026 and 542 on June 4, 2027. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-06-04 | A | A | 8,336 | $0.00 | 8,336 | D | $251.34 · — to 2034-06-04 | 8,336 Ordinary Shares | (F2) This option becomes exercisable as follows: 2,084 on June 4, 2025; 2,084 on June 4, 2026; 2,084 on June 4, 2027 and 2,084 on June 5, 2028. |